TEETHACHE DROPS

Indications

• Skin conditions (e.g., eczema, dermatitis)
• Respiratory issues (e.g., cough, cold)
• Topical antiseptic applications
• Aromatic uses for mood enhancement

Dosage

Children: Refer to relevant product-specific guidelines as doses may vary by formulation and use.

Adults: Refer to relevant product-specific guidelines as doses may vary by formulation and use.

Mechanism of action

Balsam exerts its effects primarily through its volatile compounds, which may exhibit anti-inflammatory, antiseptic, and analgesic properties. The specific pathways are not well-characterized in modern pharmacology, but traditional uses suggest modulation of inflammatory pathways and soothing of mucosal irritations.

Pharmacodynamics

Balsam compounds may influence various biological pathways, contributing to their anti-inflammatory and soothing effects. The aromatic properties can enhance mood and well-being, while topical applications are known to relieve certain skin conditions. The pharmacodynamics in humans, however, require more clinical evidence to fully elucidate their mechanisms.

Pharmacokinetics

The pharmacokinetics of balsam components are not extensively documented, but it is known that the compounds can be absorbed through the skin and mucous membranes. Metabolism primarily occurs in the liver, and elimination is expected to be via urine. However, specific half-lives and clearance rates are not well-studied.

Pregnancy

There is limited information available regarding the safety of balsam during pregnancy. It is advisable to avoid use unless clearly necessary.

Breast-feeding

Due to insufficient data on the excretion of balsam in human milk, caution is advised when using balsam while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• {'name': 'Balsam', 'molecular_formula': 'C15H24', 'description': 'Balsam is a natural resin obtained from various trees, known for its aromatic and medicinal properties. It is often used in topical preparations and alternative medicine.'}

Indications

• Respiratory tract infections
• Bronchitis
• Muscle pain
• Joint pain
• Skin irritations
• Headaches

Dosage

Children: Caution is advised when using cajuput oil in children. Generally, topical application should be performed with appropriate dilution in a carrier oil.

Adults: Topical application is common, typically diluted in a carrier oil. For respiratory issues, inhalation of steam with cajuput oil may be recommended. Refer to specific guidelines or clinical advice for detailed dosing.

Mechanism of action

Cajuput oil primarily exerts its effects through its active constituents, such as 1,8-cineole (eucalyptol), which acts as a mucolytic agent and helps to loosen mucus in the airways. Additionally, its antimicrobial properties are attributed to its ability to disrupt microbial cell membranes, leading to cell lysis. The oil may also exert anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines.

Pharmacodynamics

Cajuput oil displays a range of pharmacological effects, including analgesic, anti-inflammatory, and antispasmodic activities. Its compounds can stimulate the central nervous system and improve respiratory function, making it useful in treating conditions like bronchitis and sinusitis. The oil's local irritant properties can enhance blood flow to the applied area, contributing to pain relief.

Pharmacokinetics

The pharmacokinetics of cajuput oil are not extensively studied, but it is known that when applied topically, its components can penetrate the skin and enter systemic circulation. The absorption, distribution, metabolism, and excretion of its constituents, particularly 1,8-cineole, are influenced by factors such as formulation, route of administration, and individual patient characteristics. Inhalation of the vaporized oil can lead to rapid absorption through the respiratory tract.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal upset

Precautions

• Use cautiously in individuals with known allergies to plants in the Myrtaceae family.
• Avoid contact with eyes and mucous membranes.

Pregnancy

Caution is advised as safety during pregnancy has not been established.

Breast-feeding

Limited data available; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Topical ointments
• Inhalation solutions

Indications

• Pain relief
• Anti-inflammatory conditions
• Antimicrobial applications
• Dental pain
• Digestive disorders

Dosage

Children: Refer to healthcare professional for appropriate dosing guidelines as clove oil is generally not recommended for children without medical supervision.

Adults: For topical application, clove oil can be diluted with a carrier oil and applied as needed. For oral use, standard culinary doses are generally considered safe, but specific therapeutic doses should be guided by a healthcare professional.

Mechanism of action

Eugenol, the primary active compound in clove, exhibits its effects through several pathways. It acts as an analgesic by inhibiting the synthesis of prostaglandins, which are mediators of pain and inflammation. Additionally, eugenol has been shown to interact with voltage-gated sodium channels, which may contribute to its analgesic effects. Its antimicrobial properties are partly due to its ability to disrupt the cell membranes of bacteria and fungi.

Pharmacodynamics

Clove has a variety of pharmacodynamic effects, primarily attributed to eugenol. It exhibits analgesic, anti-inflammatory, and antioxidant properties. Clove oil has been found to reduce pain and inflammation in various experimental models. Its antimicrobial activity is effective against a range of pathogens, making it a candidate for use in oral health products. Furthermore, the antioxidant properties help in neutralizing free radicals, thereby providing protective effects against cellular damage.

Pharmacokinetics

Clove oil is absorbed through the gastrointestinal tract when ingested and can also be absorbed through the skin when applied topically. The bioavailability of eugenol can be influenced by its formulation and method of administration. Once absorbed, eugenol is distributed throughout the body, metabolized primarily in the liver, and excreted via the kidneys. The half-life of eugenol varies but is generally short, necessitating frequent dosing for sustained effects in therapeutic use.

Adverse effects

• Allergic reactions
• Gastrointestinal irritation
• Liver toxicity with excessive use
• Hypoglycemia

Interactions

• May enhance the effects of anticoagulants
• May interact with antidiabetic medications
• May reduce the effectiveness of certain antiepileptic drugs

Precautions

• Use with caution in individuals with liver disease
• Caution in patients with bleeding disorders
• Monitor blood sugar levels in diabetics

Pregnancy

Use during pregnancy is not recommended due to potential effects on the fetus.

Breast-feeding

Limited data available; use with caution as clove can affect milk production.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried whole cloves
• Powdered clove

Indications

• Constipation
• Preparation for surgical or diagnostic procedures involving the rectum
• Decreasing intraocular pressure in certain ocular conditions

Dosage

Children: For children aged 2 to 6 years, 2 g to 5 g of glycerin may be used as a suppository. Children aged 6 to 12 years may use 5 g to 10 g as needed. For specific pediatric dosing, please refer to the BNF for Children.

Adults: For rectal use, 4 g to 10 g of glycerin may be administered as a suppository as needed.

Mechanism of action

When administered rectally, glycerin draws water from the tissues into the feces due to its hygroscopic action, which reflexively stimulates bowel evacuation. Additionally, glycerin creates an osmotic gradient that leads to a decrease in intraocular pressure by facilitating fluid movement from the aqueous and vitreous humors into the bloodstream.

Pharmacodynamics

Glycerin is classified as an osmotic laxative, which acts to retain water in the fecal matter, softening stools and making them easier to pass. Its local irritant effects also contribute to its laxative properties. Glycerin suppositories typically produce a bowel movement within 15 to 30 minutes of administration.

Pharmacokinetics

Glycerin is readily absorbed from the gastrointestinal tract when taken orally and is metabolized primarily in the liver. It is distributed widely throughout the body, with excretion occurring primarily via the kidneys. The onset of action for glycerin when used as a laxative is relatively quick, particularly when used rectally.

Contra-indications

• Severe dehydration
• Severe renal impairment
• Intestinal obstruction
• Appendicitis

Adverse effects

• Abdominal cramps
• Diarrhea
• Nausea
• Vomiting
• Electrolyte imbalance

Interactions

• May enhance the effects of other laxatives
• Caution with concurrent use of diuretics due to potential electrolyte imbalance

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolytes in patients with prolonged use
• Not recommended for long-term use

Pregnancy

Glycerin is generally considered safe during pregnancy but should be used under medical advice.

Breast-feeding

Glycerin is excreted in breast milk in small amounts and is considered safe for use while breastfeeding.

Storage

Store at room temperature, away from moisture and heat.

Formulations

• Glycerin suppositories
• Glycerin oral solution

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Dosage

Children: There are no established therapeutic doses for toluene in the pediatric population. Exposure should be avoided due to potential toxicity.

Adults: There are no established therapeutic doses for toluene as it is primarily used as an industrial solvent. Exposure should be minimized due to its toxic effects.

Mechanism of action

Toluene exerts its effects primarily through its interaction with the central nervous system. It acts as a neurotoxin and can influence neurotransmitter systems, particularly those involving gamma-aminobutyric acid (GABA) and glutamate. The exact pathways are not fully elucidated, but toluene is known to enhance GABAergic activity, leading to sedative and anxiolytic effects, while also disrupting glutamate signaling, which can contribute to neurotoxicity.

Pharmacodynamics

The pharmacodynamics of toluene involve its effects on the central nervous system, where it can lead to a range of symptoms from euphoria and intoxication to neurological impairment and respiratory depression at higher exposures. Chronic exposure may result in neurobehavioral deficits, cognitive dysfunction, and potential long-term neurological damage. The effects can vary significantly based on concentration, duration of exposure, and individual susceptibility.

Pharmacokinetics

Toluene is rapidly absorbed through inhalation and dermal routes, with peak blood concentrations occurring shortly after exposure. It is metabolized primarily in the liver via cytochrome P450 enzymes, leading to the formation of various metabolites, including benzyl alcohol and hippuric acid. These metabolites are excreted in the urine. The elimination half-life of toluene varies depending on the route of exposure and individual metabolic factors, generally ranging from a few hours to a day.

Pregnancy

Toluene is not recommended during pregnancy due to potential risks to fetal development. It may cause teratogenic effects.

Breast-feeding

Toluene may be excreted in breast milk, and its use is generally not recommended while breastfeeding due to potential harm to the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight, heat, and ignition sources. Ensure containers are tightly sealed.

Mechanism of action

When administered rectally, glycerin exerts a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexively stimulating evacuation. Glycerin decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, causing fluid to move out of the aqueous and vitreous humors into the bloodstream. Glycerin (glycerol) and sorbitol are hyperosmotic laxatives. When administered rectally, glycerin and sorbitol exert a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexly stimulating evacuation. The extent to which the simple physical distention of the rectum and the hygroscopic and/or local irritant actions are responsible for the laxative effects of some of these drugs is not known. Only extremely high oral doses of sorbitol (25 g daily) or glycerin exert laxative action. /Glycerin/ decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, causing fluid to move out of the aqueous and vitreous humors into the bloodstream. The physicochemical effects of a series of alkanols, alkanediols and glycerol on erythrocyte shape and hemolysis at 4 and 20 degrees C were examined. We calculated the dielectric constant of the incubation medium, Ds, and the dielectric constant of the erythrocyte membrane Dm in the presence of organic solutes. The ratio Ds/Dm = -38.48 at 20 degrees C defines the normal biconcave shape in a medium without hemolytic agents. A decrease in Ds/Dm favors externalization or internalization with consequent hemolysis. Alkanols and alkanediols convert biconcave erythrocytes into echinocytes, which is accompanied by an increase in the projected surface area. Glycerol converts biconcave erythrocytes into stomatocytes, which was accompanied by a marginal decrease in the projected surface area. Progressive externalization in alkanols and alkanediols or internalization in glycerol resulted in a decrease in the projected surface area and the formation of smooth spheres. The degree of shape change induced was related to the degree of hemolysis and the ratio Ds/Dm. A decrease in temperature reduced both the degree of shape change and hemolysis. .../Thus/ physicochemical toxicity may be a result of a temperature dependent hydrophobic interaction between the organic solutes and the membrane and is best interpreted by the ability of the solutes to change Ds and Dm.

Pharmacodynamics

Glycerin is commonly classified as an osmotic laxative but may act additionally or alternatively through its local irritant effects; it may also have lubricating and fecal softening actions. Glycerin suppositories usually work within 15 to 30 minutes.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/